Indivior Inc.

This study tested two different doses (100 mg vs 300 mg) of a monthly buprenorphine shot in 785 adults with moderate to severe opioid use disorder. The goal was to see which dose helped people stay in treatment and reduce opioid use. Results showed how well each dose worked for m…

This study tested a new medication called INDV-2000 in 300 adults with moderate to severe opioid use disorder who had recently started or completed withdrawal treatment. The goal was to see if INDV-2000 could help them stay opioid-free for 3 months without needing another opioid …

This study looked at how a new injectable medication, INDV-6001, works in the body and whether it is safe for adults with moderate to severe opioid use disorder. 123 participants received multiple doses, and researchers checked drug levels and side effects. The goal was to find t…

This study followed 480 adults with opioid use disorder who were taking SUBLOCADE, a long-acting medication to control cravings and withdrawal. Researchers watched participants for up to 4 years to see how their drug use, health, and daily life changed over time. The goal was to …

This study followed 12 adults with opioid use disorder who had been stable on SUBLOCADE for at least 9 months and decided with their doctor to stop treatment. Researchers tracked whether participants could successfully taper off without relapsing or needing to restart long-term m…